HARLAN S ROBINS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for HARLAN S ROBINS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of HARLAN S ROBINS. HARLAN S ROBINS is Chief Scientific Officer in Adaptive Biotechnologies Corp ($ADPT).
Latest Insider Trading Transactions of HARLAN S ROBINS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 46.84 | 6,657 | 311,814 | 4,422 | 11.1 K to 4.4 K (-60.09 %) |
| Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 45.36 | 700 | 31,752 | 11,079 | 11.8 K to 11.1 K (-5.94 %) |
| Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
| Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 46.38 | 2,823 | 130,931 | 679 | 3.5 K to 679 (-80.61 %) |
| Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 45.72 | 8,277 | 378,424 | 3,502 | 11.8 K to 3.5 K (-70.27 %) |
| Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
| Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 46.95 | 9,600 | 450,720 | 679 | 10.3 K to 679 (-93.39 %) |
| Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 46.21 | 1,500 | 69,315 | 10,279 | 11.8 K to 10.3 K (-12.73 %) |
| Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
| May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 40.48 | 31,372 | 1,269,939 | 679 | 32.1 K to 679 (-97.88 %) |
| May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 40.11 | 38,628 | 1,549,369 | 32,051 | 70.7 K to 32.1 K (-54.65 %) |
| May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 40.48 | 31,372 | 1,269,939 | 679 | 32.1 K to 679 (-97.88 %) |
| May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 40.11 | 38,628 | 1,549,369 | 32,051 | 70.7 K to 32.1 K (-54.65 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 433,500 | |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 35,400 | 223,728 | 444,600 | |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 433,500 | |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 31,200 | 197,184 | 480,000 | |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 35,400 | 223,728 | 444,600 | |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 39.36 | 10,500 | 413,280 | 70,679 | 81.2 K to 70.7 K (-12.93 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 31,200 | 197,184 | 480,000 | |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 38.67 | 600 | 23,202 | 81,179 | 81.8 K to 81.2 K (-0.73 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 39.36 | 10,500 | 413,280 | 70,679 | 81.2 K to 70.7 K (-12.93 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 81,779 | 70.7 K to 81.8 K (+15.70 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 38.67 | 600 | 23,202 | 81,179 | 81.8 K to 81.2 K (-0.73 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 38.11 | 7,158 | 272,791 | 70,679 | 77.8 K to 70.7 K (-9.20 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 81,779 | 70.7 K to 81.8 K (+15.70 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 37.53 | 22,342 | 838,495 | 77,837 | 100.2 K to 77.8 K (-22.30 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 38.11 | 7,158 | 272,791 | 70,679 | 77.8 K to 70.7 K (-9.20 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 36.34 | 5,400 | 196,236 | 100,179 | 105.6 K to 100.2 K (-5.11 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 37.53 | 22,342 | 838,495 | 77,837 | 100.2 K to 77.8 K (-22.30 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 35.13 | 400 | 14,052 | 105,579 | 106 K to 105.6 K (-0.38 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 36.34 | 5,400 | 196,236 | 100,179 | 105.6 K to 100.2 K (-5.11 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 33.56 | 100 | 3,356 | 105,979 | 106.1 K to 106 K (-0.09 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 35.13 | 400 | 14,052 | 105,579 | 106 K to 105.6 K (-0.38 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 33.56 | 100 | 3,356 | 105,979 | 106.1 K to 106 K (-0.09 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 35,400 | 223,728 | 106,079 | 70.7 K to 106.1 K (+50.09 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 35,400 | 223,728 | 106,079 | 70.7 K to 106.1 K (+50.09 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 35.44 | 28,000 | 992,320 | 70,679 | 98.7 K to 70.7 K (-28.37 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 35.44 | 28,000 | 992,320 | 70,679 | 98.7 K to 70.7 K (-28.37 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 34.26 | 3,200 | 109,632 | 98,679 | 101.9 K to 98.7 K (-3.14 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 34.26 | 3,200 | 109,632 | 98,679 | 101.9 K to 98.7 K (-3.14 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 31,200 | 197,184 | 101,879 | 70.7 K to 101.9 K (+44.14 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 31,200 | 197,184 | 101,879 | 70.7 K to 101.9 K (+44.14 %) |
| Apr 22 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 25,600 | 161,792 | 511,200 | |
| Apr 22 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 3,900 | 24,648 | 536,800 | |
| Apr 22 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 14,900 | 94,168 | 540,700 | |
| Apr 22 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 30.28 | 25,500 | 772,140 | 70,679 | 96.2 K to 70.7 K (-26.51 %) |
| Apr 22 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 29.63 | 100 | 2,963 | 96,179 | 96.3 K to 96.2 K (-0.10 %) |
| Apr 22 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 25,600 | 161,792 | 96,279 | 70.7 K to 96.3 K (+36.22 %) |
| Apr 22 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 29.50 | 2,697 | 79,562 | 70,679 | 73.4 K to 70.7 K (-3.68 %) |
| Apr 22 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 28.55 | 1,203 | 34,346 | 73,376 | 74.6 K to 73.4 K (-1.61 %) |
| Apr 22 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 3,900 | 24,648 | 74,579 | 70.7 K to 74.6 K (+5.52 %) |
| Apr 22 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 29.58 | 4,988 | 147,545 | 70,679 | 75.7 K to 70.7 K (-6.59 %) |
| Apr 22 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 28.63 | 7,912 | 226,521 | 75,667 | 83.6 K to 75.7 K (-9.47 %) |
| Apr 22 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 27.72 | 2,000 | 55,440 | 83,579 | 85.6 K to 83.6 K (-2.34 %) |
| Apr 22 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 14,900 | 94,168 | 85,579 | 70.7 K to 85.6 K (+21.08 %) |
| Feb 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 7,400 | 46,768 | 555,600 | |
| Feb 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 33.53 | 6,600 | 221,298 | 70,679 | 77.3 K to 70.7 K (-8.54 %) |
| Feb 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 32.85 | 800 | 26,280 | 77,279 | 78.1 K to 77.3 K (-1.02 %) |
| Feb 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 7,400 | 46,768 | 78,079 | 70.7 K to 78.1 K (+10.47 %) |
| Feb 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | A | 31.71 | 300,000 | 9,513,000 | 300,000 | |
| Jan 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 3,700 | 23,384 | 588,900 | |
| Jan 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 3,700 | 23,384 | 592,600 | |
| Jan 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 3,700 | 23,384 | 596,300 | |
| Jan 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 28.30 | 2,400 | 67,920 | 70,679 | 73.1 K to 70.7 K (-3.28 %) |
| Jan 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 27.33 | 1,300 | 35,529 | 73,079 | 74.4 K to 73.1 K (-1.75 %) |
| Jan 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 3,700 | 23,384 | 74,379 | 70.7 K to 74.4 K (+5.23 %) |
| Jan 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 29.54 | 1,300 | 38,402 | 70,679 | 72 K to 70.7 K (-1.81 %) |
| Jan 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 28.98 | 1,300 | 37,674 | 71,979 | 73.3 K to 72 K (-1.77 %) |
| Jan 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 27.80 | 1,100 | 30,580 | 73,279 | 74.4 K to 73.3 K (-1.48 %) |
| Jan 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 3,700 | 23,384 | 74,379 | 70.7 K to 74.4 K (+5.23 %) |
| Jan 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 29.52 | 3,700 | 109,224 | 70,679 | 74.4 K to 70.7 K (-4.97 %) |
| Jan 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 3,700 | 23,384 | 74,379 | 70.7 K to 74.4 K (+5.23 %) |
| Jul 03 2019 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | C | 0.00 | 70,679 | 0 | 0 | |
| Jul 03 2019 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | C | 0.00 | 70,679 | 0 | 70,679 | 0 to 70.7 K |